Lock catheter type in hemodialysis patients. Sequelae of adverse incidents associated with medical devices in diagnostic and therapeutic use
Conditions
Interventions
Intervention 1: Intervention group: 29 patients treated with Citralac in dialysis catheter (Sodium Citrate 4%).The nurse in charge of each patient, according to the activeness of the dialysis center
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Under routine weekly hemodialysis Patients aged 18-80 years Have a central vein catheter (internal jugular, subclavian and femoral) Have normal coagulation function Have a properly functioning catheter
Exclusion criteria
Exclusion criteria: having a local or systemic infection caused by the catheter (currently or less than 2 weeks) Suffering from a systemic infection except catheter infection (pulmonary, urinary, etc.) Women during pregnancy, perinatal or breastfeeding Abnormal coagulation function Patients with allergies to heparin or sodium citrate or coagulation disorders Treated with immunosuppressive drugs having a fistula
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fever and chills and systemic signs of infection or local complications of the catheter site (sensitivity to the touch, stiffness, redness of the catheter insertion site, infection in the catheter insertion site) and blood coagulation indices, plt, bleeding around the catheter insertion site and the amount Subcutaneous hematoma, catheter blockage, calcium and albumin levels. Timepoint: At the beginning of the study and then monthly for three months. Method of measurement: Laboratory data and examination of patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahsa Kohan sal Vajargah
Iran University of Medical Sciences
Outcome results
None listed